Chronic Infection Considerations in Nonalcoholic Fatty Liver Disease Patients
Gene Expression · 2023
DOI: 10.14218/ge.2022.00007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Expression, 2023. Verfasst von Xiaoqian Ding und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Nonalcoholic fatty-liver disease (NAFLD) has become one of the most common and important chronic liver diseases worldwide. Some chronic infectious diseases are associated with the risk of NAFLD. These can induce abnormal glucose and lipid metabolism, insulin resistance, inflammatory activation and other responses, which increase the risk of progression of liver fibrosis. The present study describes the pathogenesis and management of NAFLD with chronic infectious diseases, such as hepatitis B virus, hepatitis C virus, Helicobacter pylori, and human immunodeficiency virus infections.
Zitieren
APA
Ding, X., Zhao, Z., Liu, S., Zhang, J., Zhou, Y., & Xin, Y. (2023). Chronic Infection Considerations in Nonalcoholic Fatty Liver Disease Patients. Gene Expression. https://doi.org/10.14218/ge.2022.00007
Vancouver
Ding X, Zhao Z, Liu S, Zhang J, Zhou Y, Xin Y. Chronic Infection Considerations in Nonalcoholic Fatty Liver Disease Patients. Gene Expression. 2023. doi:10.14218/ge.2022.00007
BibTeX
@article{Ding2023,
author = {Ding, Xiaoqian and Zhao, Zhenzhen and Liu, Shousheng and Zhang, Jie and Zhou, Yong and Xin, Yongning},
title = {Chronic Infection Considerations in Nonalcoholic Fatty Liver Disease Patients},
journal = {Gene Expression},
year = {2023},
doi = {10.14218/ge.2022.00007}
}
EUVIMED